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Deliberate exposure of animals  to  antigen  via the  gastrointestinal  tract  has  long 
been an established means of producing a state of systemic hyporesponsiveness to the 
same  antigen  when  subsequently  presented  in  immunogenic  form  (1-7).  Although 
tolerance  induced  by  enteric  antigen  exposure  has  been  extensively studied,  little 
attention has been paid to the relationship of this phenomenon to autoimmunity.  In 
particular, the responses of spontaneously autoimmune mice to enteric immunization 
have  not  been  evaluated.  Consequently,  a  simple  method  of studying  tolerance  in 
autoimmune  mice has  been  overlooked. In  this  report,  we demonstrate  that,  under 
appropriate conditions, NZB mice are resistant to the induction of systemic tolerance 
by prior enteric exposure to ovalbumin (OVA). This finding may provide a  means of 
studying antigen-specific suppressor mechanisms in autoimmunity. 
Materials and Methods 
Mice.  NZB/N  mice  were  from  colonies  maintained  at  the  NIH.  C57BL/6J  mice  were 
obtained from The Jackson Laboratory, Bar Harbor, ME. Only female mice were used;  they 
were 8 wk old at the start of the experiment. All mice were fed mouse chow that was free of any 
chicken or egg products. 
Gastric Intubation.  OVA, five times recrystallized, purchased  from  Sigma Chemical Com- 
pany, St. Louis, MO, was dissolved in saline at a concentration of 50 mg/ml. Antigen feeding 
was  carried  out  under  light  ether  anesthesia  by  the  intragastric  administration  of 0.4  ml 
(containing 20 mg) of the OVA solution via 0.58-mm interior diameter polyethylene tubing. 
Control animals received 0.4 ml of saline. 
Measurement of Anti-OVA Response.  A modified Farr assay was used to measure antibodies to 
OVA. Serum was diluted in borate-buffered saline (BBS), and 50/zl was incubated in 10 ×  75- 
mm borosilicate glass  centrifuge tubes with  1 /~g of all-labeled OVA (0.1 #Ci/#g)  in 50 pl of 
BBS containing 1% bovine serum albumin. The mixture was incubated for 30 min at 37°C and 
overnight at 4°C;  100/zl of 85% saturated ammonium sulfate was then added to each sample. 
After a  1 h incubation in an ice water bath, the samples were centrifuged at 1,500 g for 20 min. 
One-half (100 /zl) of the  total  volume was  removed, and  the  percent  binding of OVA was 
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Fxa.  1.  Groups of eight C57BL/6 or NZB females (8 wk of age) were given either 0.2 ml of saline 
only or 0.2 ml of saline containing 20 mg of OVA on day 0. On day 7, animals were challenged with 
125/~g of OVA in CFA; antigen-binding capacity (ABC,3) was determined on day 21  (14 d after 
challenge).  NS, not significant. 
determined as follows: percent binding =  ([1  -  cpm sample]/[xh input cpm])  ×  100.  Antigen- 
binding capacities (ABC33) were calculated using a semi-log plot as described previously (8). 
Immunizations and Bleeding Schedules.  All mice were immunized with OVA 7 d  after antigen 
feeding. For evaluation of primary responses, animals were challenged with a single intraperi- 
toneal  injection of 125  pg OVA in complete adjuvant  (H37Ra;  Difco Laboratories,  Detroit, 
MI)  and were bled by orbital sinus puncture  14 d  after immunization.  Secondary responses 
were evaluated by immunizing mice with an intraperitoneal  injection of 0.2 ml of a  mixture 
containing 25/~g/ml OVA and 25 mg/ml alum  (OVA/alum). All animals were challenged 7 
and 21  d  after OVA feeding and were bled 7 d  after the second challenge. The dose of OVA 
and the timing of serum collection was determined  previously by experiments that  evaluated 
both the dose-response relationship and the kinetics of the response  (data not shown).  OVA/ 
alum-immunized mice were given a  third intraperitoneal  injection of 0.2 ml OVA/alum 60 d 
after the second challenge (81  d  after OVA feeding); they were bled 7 d  later. The specificity 
of tolerance was determined by immunizing OVA or saline-fed mice intraperitoneally with 5 
×  l0  s sheep erythrocytes  (SRBC)  or intravenously with  10 ~g of TNP35-AECM-Ficoll, (Bio- 
search,  San Rafael, CA). Serum anti-SRBC antibody titers were measured  7 d  after immuni- 
zation  by  hemagglutination;  serum  anti-TNP  levels were  determined  5  d  after  TNP-Ficoll 
challenge by a  modified Farr assay, as previously described (9). 
Results 
OVA feeding produced hyporesponsiveness to OVA in C57BL/6 mice but did not 
diminish  the primary NZB  anti-OVA  response  (Fig.  1).  A  possible explanation of 
these findings is that NZB mice were primed by intragastric immunization. To test C57 BL/6 
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Fro.  2.  Groups of eight C57BL/6 or NZB females (8 wk of age) were given either 0.2  ml of saline 
or 0.2  ml  of saline containing  20  mg of OVA on  day  0.  On  days  7 and  21,  mice  received  an 
intraperitoneal injection of 5/~g of OVA/alum Antigen-binding capacity (ABC33) was determined 
on day 28 (7 d after boost). 
this  hypothesis,  we  evaluated  secondary  anti-OVA  responses  by  twice  challenging 
OVA-fed  or control  animals  with  25 /~g of OVA  adsorbed  to  5  mg of alum.  This 
represented a  milder form of challenge, as unmanipulated  mice of either strain failed 
to show a significant serum anti-OVA response either 7 or 14 d after a single injection 
of alum-precipitated  OVA; however, a  vigorous anti-OVA response could be seen  7 
d  after a  second intraperitoneal  injection given  14 d  after the first  (data not shown). 
When we evaluated the effect of OVA feeding on this priming-dependent,  secondary 
response,  we  found  that  both  C57BL/6  and  NZB  mice  were  tolerant  to  a  similar 
degree  (Fig.  2);  thus,  we  found no evidence of systemic priming  in  OVA-fed NZB 
mice. 
Before  concluding  that  NZB  mice  could  be  normally  tolerized  with  respect  to 
secondary  responses,  both  C57BL/6  and  NZB  mice  were  rechallenged  with  OVA 
adsorbed to alum  to assess the duration  of tolerance  in both strains.  This procedure 
represented  a  third  injection  of OVA  given  60  d  after  the  second.  The  results, 
presented in Fig. 3, indicate that the tolerant state seen in OVA-fed animals persisted 
for at least 81  d  after antigen  feeding. 
To rule out the unlikely possibility that OVA-fed mice were generally hyporespon- 
sive, they were challenged with either SRBC or TNP-FicolI. The OVA-fed mice made 
antibody responses to those irrelevant antigens comparable to the responses of controls 
(Table I). Thus, the hyporesponsiveness of OVA-fed mice was antigen specific. C57 BL/6 
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Fro.  3.  Animals presented in Fig. 2 were given a third injection of OVA/alum 60 d after secondary 
immunization (81  d  after OVA feeding). Antigen-binding capacity  (ABC33) was determined  7 d 
later. 
TABLE  I 
The Response of OVAofed and Control Mice to Unrelated Antigens 
Strain  Intragastric  Anti-SRBC*  Anti-TNP:~ 
treatment 
C57BL/6  Saline  4.4 ±  0.5  53.6 ±  4.1 
OVA  4.6 +  0.8  48.4 ±  2.2 
NZB  Saline  5,4 +  0.5  63.0 ±  2.0 
OVA  5.6 ±  0.5  58.6 ±  2.1 
* Hemagglutination titer (X log2 +-. SEM)  7 d  after intraperitoneal injection 
with 5 ×  l0  s SRBC. 
~: Percent  binding of 500  ng of 12~I-DNP-BSA by  15 pl of sera obtained 5 d 
after immunization with 10 #g of TNP-FicolI. Normal mouse serum showed 
<15% binding. 
Discussion 
A defect in systemic tolerance after OVA feeding and primary challenge with OVA 
in  complete adjuvant  represents  a  previously undescribed  regulatory  defect  in  the 
autoimmune-prone NZB strain. Their resistance to tolerance differs from the recently 
reported resistance of C3H/HeJ mice to tolerance induced by SRBC feeding (10,  11). 
Unlike the C3H/HeJ mice in that study, NZB mice showed no evidence of priming 
as  a  result  of enteric  antigen  exposure.  Nevertheless,  the  NZB  mouse  represents  a 
second  strain  that,  under  appropriate  study  conditions,  is  resistance  to  tolerance 
induction  by antigen feeding. Moreover, the NZB mice used in this study were 8 wk 1260  COWDERY ET AL.  BRIEF  DEFINITIVE REPORT 
old; therefore, defective tolerance induction cannot be ascribed to the severe clinical 
manifestations of autoimmunity that such mice develop later in life. 
NZB mice are known to be resistant to the induction of tolerance by the injection 
of deaggregated gamma globulins (12,  13) ; however, the immune mechanisms respon- 
sible for systemic tolerance after antigen  feeding contrast with the tolerance mecha- 
nisms in  recipients of deaggregated protein. A  major difference is the larger role of 
suppressor  T  cells  in  the  production  and  maintenance  of tolerance  after  enteric 
antigen exposure. Although a  defect in the T  suppressor cell compartment has been 
ascribed  to NZB mice (14),  a  defect  in  antigen-specific T  suppressor cells has been 
elusive (15).  The study of defective tolerance after antigen feeding may be a means of 
defining such a defect. 
The tolerance resistance of NZB mice reported in this study was observed only at 
the level of the primary response. This result may be influenced by the dose of antigen 
involved (or the complete adjuvant) that is required to generate a reasonable primary 
anti-OVA response.  According to such  reasoning,  defective tolerance  in  NZB  mice 
may become apparent only when the relative strength of the antigenic challenge  is 
increased; small repetitive doses of antigen may not provide sufficient stimulation to 
break tolerance. Alternatively, the possibility exists that the mechanisms responsible 
for regulating  primary and  secondary responses  are  different.  Consistent  with  this 
hypothesis is the observation that NZB mice usually have normal secondary responses 
at  a  time when  primary responses  are  abnormal  (15,  16). Thus,  the  abnormality 
observed in NZB mice could be the result of a  specific defect in  the regulation of a 
primary response. 
Tolerance to repetitive low-dose antigen challenge was seen in both C57BL/6 and 
NZB  mice after a  single  intragastric  administration  of OVA.  This  represented  the 
initial exposure of these animals to OVA, and the observed systemic tolerance may 
mimic the natural state of original enteric exposure to a  multitude of antigens. This 
mode  of  antigen  exposure  may  result  in  local  secretory  immunity  but  systemic 
tolerance to the small amount of antigen  that may be absorbed intact.  The present 
study suggests that NZB mice are probably normal in this regard. This finding is of 
interest  to the experimental treatment of autoimmunity in that  repeated feeding of 
antigen has been shown to reduce the magnitude of an ongoing immune response (7). 
It is possible that repetitive feeding of relevant self antigens (not usually presented via 
the gastrointestinal tract) may be able to modulate autoimmune responses. 
Summary 
We evaluated the effect of antigen feeding on the subsequent primary and secondary 
anti-ovalbumin (OVA) responses of C57BL/6 and NZB mice. When C57BL/6 mice 
were  given  a  single  20-mg  dose  of OVA  intragastrically,  profound  tolerance  was 
observed after challenge, 7 d later, with  125/lg of OVA in complete adjuvant or after 
two  injections  of 5  /~g of OVA  adsorbed  to  alum  given  7  and  21  d  after  antigen 
feeding. OVA-fed NZB mice failed to become tolerant  to a  primary challenge with 
OVA  in  complete  adjuvant,  but  showed  a  degree  of tolerance  similar  to  that  of 
C57BL/6 mice when challenged two or three times with OVA in alum. These studies 
demonstrate that NZB mice fail to show tolerance at the level of the primary response 
after antigen feeding; however, they are normally tolerant when a secondary response 
to a lower dose of antigen is evaluated. This study suggests that, after antigen feeding, COWDERY  ET AL.  BRIEF DEFINITIVE REPORT  1261 
different mechanisms of tolerance may be involved in the regulation of primary and 
secondary responses. 
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